Comparison of biomarker levels (sHER2, CA15.3 and CEA) over time (Day 1, 30 and 90) and according to the therapeutic response to treatment of HER2-positive metastatic breast cancer patients with a combination of trastuzumab and paclitaxel.
收藏Figshare2020-01-07 更新2026-04-28 收录
下载链接：
https://figshare.com/articles/dataset/Comparison_of_biomarker_levels_sHER2_CA15_3_and_CEA_over_time_Day_1_30_and_90_and_according_to_the_therapeutic_response_to_treatment_of_HER2-positive_metastatic_breast_cancer_patients_with_a_combination_of_trastuzumab_and_paclitaxel_/11542260
下载链接
链接失效反馈官方服务：
资源简介：
Comparison of biomarker levels (sHER2, CA15.3 and CEA) over time (Day 1, 30 and 90) and according to the therapeutic response to treatment of HER2-positive metastatic breast cancer patients with a combination of trastuzumab and paclitaxel.
创建时间：
2020-01-07
